High-Performance Healthcare Materials And Sustainable Polymers Will Create Value

Published
02 Sep 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
US$41.71
21.3% undervalued intrinsic discount
07 Aug
US$32.82
Loading
1Y
-26.8%
7D
-3.5%

Author's Valuation

US$41.7

21.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 May 25
Fair value Decreased 3.48%

Shared on30 Apr 25
Fair value Decreased 0.32%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 4.68%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 7.60%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 14%

AnalystConsensusTarget has decreased revenue growth from 3.7% to 3.3%.

Shared on02 Apr 25
Fair value Decreased 19%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 3.32%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Increased 28%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.